Resistant Hypertension: Insights on Evaluation and Management in the Post-SPRINT (Systolic Blood Pressure Intervention Trial) Era.
From the Perelman School of Medicine, University of Pennsylvania, Philadelphia; and Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, FL. townsend@upenn.edu.
Raymond R
RR
Townsend
From the Perelman School of Medicine, University of Pennsylvania, Philadelphia; and Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, FL.
Murray
M
Epstein
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D001795:Blood Pressure Determination; D015897:Comorbidity; D004351:Drug Resistance; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D008019:Life Style; D008297:Male; D054539:Medication Therapy Management / Q000592:standards*; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D016896:Treatment Outcome; D014481:United States
D000959:Antihypertensive Agents